ResearcherTechnische Universität DresdenActive in the last 2 years

Jens Pietzsch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1610-1493; OpenAlex author ID A5086741053. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 8

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 4

A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression. Co-author DOI 10.1016/j.biomaterials.2025.123456 ↗
Sex determines the natural killer cell-mediated immunity against pancreatic cancer. Co-author DOI 10.1080/2162402x.2026.2645298 ↗
Investigation of the Putative Relationship Between Copper Transport and the Anticancer Activity of Cisplatin in Ductal Pancreatic Adenocarcinoma. Last author DOI 10.3390/cells14191489 ↗
Combined PET Radiotracer Approach Reveals Insights into Stromal Cell-Induced Metabolic Changes in Pancreatic Cancer In Vitro and In Vivo. Last author DOI 10.3390/cancers16193393 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alina Doctor · 2 shared papers, 2024–2025 · strength 0.61
- Paper Investigation of the Putative Relationship Between Copper Transport and the Anticancer Activity of Cisplatin in Ductal … DOI 10.3390/cells14191489 ↗
- Paper Combined PET Radiotracer Approach Reveals Insights into Stromal Cell-Induced Metabolic Changes in Pancreatic Cancer In … DOI 10.3390/cancers16193393 ↗
Ivonne Bazwinsky‐Wutschke · 1 shared paper, 2026 · strength 0.26
- Paper Sex determines the natural killer cell-mediated immunity against pancreatic cancer. DOI 10.1080/2162402x.2026.2645298 ↗
Elise Arlt · 1 shared paper, 2026 · strength 0.26
- Paper Sex determines the natural killer cell-mediated immunity against pancreatic cancer. DOI 10.1080/2162402x.2026.2645298 ↗
Daniela Loessner · 1 shared paper, 2026 · strength 0.25
- Paper A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutro… DOI 10.1016/j.biomaterials.2025.123456 ↗
Franziska Baenke · 1 shared paper, 2026 · strength 0.25
- Paper A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutro… DOI 10.1016/j.biomaterials.2025.123456 ↗
Michael Seifert · 1 shared paper, 2026 · strength 0.25
- Paper A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutro… DOI 10.1016/j.biomaterials.2025.123456 ↗
Verena Kast · 1 shared paper, 2026 · strength 0.25
- Paper A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutro… DOI 10.1016/j.biomaterials.2025.123456 ↗
Daniel E. Stange · 1 shared paper, 2026 · strength 0.25
- Paper A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutro… DOI 10.1016/j.biomaterials.2025.123456 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.